In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Monsanto, Pharmacia & Upjohn to merge

Executive Summary

Monsanto and Pharmacia & Upjohn have agreed to combine companies in a tax-free pooling of interests valuing Pharmacia & Upjohn at $26.7bn. P&U shareowners will receive 1.19 shares (at a (pr)4% discount) for each common they hold; each Monsanto share will represent one share in the combined company. Monsanto shareowners will own approximately 51% of the new company.
Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Full Acquisition
    • Payment Includes Stock

Related Companies